The actual use of fetal gated cardiovascular magnetic resonance imaging : a worldwide survey
Author Block: G. Gourincour1, H. Boeth2, F. Kording2, D. Grevent3, R. Chaoui4, L. J. Salomon3; 1Marseille/FR, 2Hamburg/DE, 3Paris/FR, 4Berlin/DE
Purpose: To study the clinical and research use of fetal smart-sync cardiovascular magnetic resonance imaging (F-ss-CV-MRI) worldwide
Methods or Background: Extensive survey sent to 70 centers equipped with the device. Questions concerned project-leading specialty, country, setting, quantitative and qualitative user analysis, degree of satisfaction and remaining needs
Results or Findings: 30 centers answered (43 %). In 19 (63 %) team was lead by radiologists, in 8 (27 %) by cardiologists, and in 3 (10 %) by researchers. Thirteen centers were in the US (43 %), 4 (13 %) in Germany, 3 (10 %) in France, 2 (6.7 %) in the Netherlands, Sweden and the UK, and 1 (3.3 %) in Italy, Switzerland and Israel. Setting was academic in 23 (77 %), hospital-based in 16 (54 %) and private in 2 (6.7 %).
Centers have been users for a mean of 21.6 months (Min 1, max 48), with a mean number of exams of 33.2 (Min 2, Max 200). Twenty-eight centers perform MRI between 30 and 35 weeks’ gestation (WG), 8 after 35 WG and 4 before 30 WG. In 19 centers it is performed for clinics and research, in 6 only for clinics and in 6 only research.
Twenty-four centers (80 %) rate as high/very high the improvement and would recommend it.
Clinical situations when it would be recommended were mostly unclear complex congenital heart disease with need for improved delineation
Conclusion: F-ss-CV-MRI is a promising technique which needs shorter sequences, better consistency and wider diffusion
Limitations: Image quality for 10 centers (33 %), convincing their referrals for 8 (27 %), and MR accessibility for 8 (27).
Fourteen centers (47 %) consider that it has not yet an impact on diagnosis but 24 (80 %) believe it will have
Funding for this study: None
Has your study been approved by an ethics committee? Not applicable
Ethics committee - additional information: